Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Adenosine impairs the proliferative capacity of terminally mature NK cells

ABSTRACT: Adenosine impairs the proliferative capacity of terminally mature NK cells

PROVIDER: PRJEB22631 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR2119810.fastq.gz	Fastqsanger.gz
	ERR2119811.fastq.gz	Fastqsanger.gz
	ERR2119802.fastq.gz	Fastqsanger.gz
	ERR2119812.fastq.gz	Fastqsanger.gz
	ERR2119803.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

Liver-Specific Overexpression of HKDC1 Increases Hepatocyte Size and Proliferative Capacity

Project description:Liver-Specific Overexpression of HKDC1 Increases Hepatocyte Size and Proliferative Capacity

| PRJNA945469 | ENA

Small molecule oxybutynin rescues proliferative capacity of complex III-defective MPCs

Project description:Small molecule oxybutynin rescues proliferative capacity of complex III-defective MPCs

| PRJNA1188628 | ENA

Conversion of terminally committed hepatocytes to culturable bipotent progenitor cells with regenerative capacity

Project description:A challenge for advancing approaches to liver regeneration is loss of functional differentiation capacity when hepatocyte progenitors are maintained in culture. Recent lineage-tracing studies have shown that mature hepatocytes (MHs) convert to an immature state during chronic liver injury, and we investigated whether this conversion could be recapitulated in vitro and if such converted cells could represent a source of expandable hepatocytes. We report that a cocktail of small molecules, Y-27632, A-83-01 and CHIR99021, can convert rat and mouse MHs in vitro into proliferative bipotent cells, which we term chemically induced liver progenitors (CLiPs). CLiPs can differentiate into both MHs and biliary epithelial cells that can form functional ductal structures. CLiPs in long-term culture did not lose their proliferative capacity or their hepatic differentiation ability, and rat CLiPs were shown to extensively repopulate chronically injured liver tissue. Thus our study advances the goals of liver regenerative medicine. Transcriptomic analyses for freshly isolated MHs and cells cultured for the designated periods with or without YAC stimulation (Matrix 1). Transcriptomic analysis for CLiPs which underwent hepatic induction (Matrix 2). Transcriptomic comparison of hepatic inducibility between CLiPs at early passage and those at late passages (Matrix 3). Transcriptomic comparison between chimera-derived rat cells (designated as “2nd”) and primary rat MH-derived cells (designated as “1st”) (Matrix 4).

2016-11-15 | GSE87611 | GEO

Dietary cystine restriction increases the proliferative capacity of the small intestine of mice

Project description:Dietary cystine restriction increases the proliferative capacity of the small intestine of mice

| PRJNA982067 | ENA

Dietary cystine restriction increases the proliferative capacity of the small intestine of mice

Project description:Dietary cystine restriction increases the proliferative capacity of the small intestine of mice

| PRJEB63227 | ENA

TIM-3 + CD8 T cells with a terminally exhausted phenotype retain functional capacity in hematological malignancies

Project description:TIM-3 + CD8 T cells with a terminally exhausted phenotype retain functional capacity in hematological malignancies

| PRJNA1091196 | ENA

Newborn apical resection preserves the proliferative capacity of cardiomyocytes located throughout the left ventricle

Project description:Newborn apical resection preserves the proliferative capacity of cardiomyocytes located throughout the left ventricle

| PRJNA1242376 | ENA

Enabling adenosine signaling to promote aged fracture healing

Project description:Despite its regenerative capacity, the healing potential of bone tissue declines with aging. With the increase in global aging population, bone fractures pose a tremendous burden to the healthcare system. Therapeutic interventions that circumvent age-associated impairments and promote bone tissue regeneration are attractive options for geriatric fracture repair. We and others have demonstrated the role of extracellular adenosine in bone homeostasis and regeneration. Herein, we examined the changes in extracellular adenosine with aging and the potential of local delivery of adenosine to promote fracture healing using aged mice as a model system. Extracellular adenosine level was significantly lower in aged bone tissue compared to those from young mice. Concomitantly, the ecto-5′-nucleotidase CD73 expression was also found to be lower in the aged bone tissue. Local delivery of adenosine using injectable, in situ curing microgel delivery units yielded a pro-regenerative environment and promoted fracture healing in aged mice. This study offers new insights into age-related physiological changes in adenosine levels and demonstrates the therapeutic potential of adenosine supplementation to circumvent the compromised healing of geriatric fractures.

2025-04-16 | GSE272155 | GEO

Small molecule oxybutynin rescues proliferative capacity of complex III-defective MPCs

Project description:Mitochondrial disease encompasses a group of genetically inherited disorders hallmarked by an inability of the respiratory chain to produce sufficient ATP. These disorders present with multisystemic pathologies that predominantly impact highly energetic tissues such as skeletal muscle. There is no cure or effective treatment for mitochondrial disease. We have discovered a small molecule known as oxybutynin that can bypass Complex III mitochondrial dysfunction in primary murine and human skeletal muscle progenitor cells (MPCs). Oxybutynin administration improves MPC proliferative capacity, enhances cellular glycolytic function, and improves myotube formation. Mechanistically, results from our isothermal shift assay indicates that oxybutynin interacts with a suite of proteins involved in mRNA processing which then trigger the upregulation biological pathways to circumvent CIII mitochondrial dysfunction. Taken together, we provide evidence for the small molecule oxybutynin as a potential therapeutic candidate for the future treatment of CIII mitochondrial dysfunction.

2024-11-25 | GSE282462 | GEO

Rat MeDIP Array, naïve, epileptic, and adenosine treated

Project description:Epilepsy causes altered gene expression; transient adenosine treatment inhibits progression of epileptogenesis Hippocampus of epileptic rat is hypermethylated compared to naïve; adenosine treatment causes hypomethylation Metylation state in epileptic rats (9 weeks post kainic acid induced status epilepticus) was compared to naïve (untreated) rats and epileptic rats treated with adenosine for 5 days

2013-09-05 | E-GEOD-45932 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data